Your browser doesn't support javascript.
loading
The effect of medical and urologic disorders on the survival of patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide.
Serrano Domingo, Juan José; Alonso Gordoa, Teresa; Lorca Álvaro, Javier; Molina-Cerrillo, Javier; Barquín García, Arantzazu; Martínez Sáez, Olga; Burgos Revilla, Javier; Carrato, Alfredo; Álvarez Rodríguez, Sara.
Affiliation
  • Serrano Domingo JJ; Medical Oncology Department, University Hospital Ramon y Cajal, Madrid, Spain.
  • Alonso Gordoa T; Medical Oncology Department, University Hospital Ramon y Cajal, Ctra. Colmenar km9100, Madrid, 28034, Spain.
  • Lorca Álvaro J; Urology Department, University Hospital Ramon y Cajal, Madrid, Spain.
  • Molina-Cerrillo J; Medical Oncology Department, University Hospital Ramon y Cajal, Madrid, Spain.
  • Barquín García A; Medical Oncology Department, Centro Integral Oncológico Clara Campal, Hospitales Madrid, Madrid, Spain.
  • Martínez Sáez O; Medical Oncology Department, Hospital Clinic I Provincial, Barcelona, Spain.
  • Burgos Revilla J; Urology Department, University Hospital Ramon y Cajal, Madrid, Spain.
  • Carrato A; Medical Oncology Department, University Hospital Ramon y Cajal, Madrid, Spain.
  • Álvarez Rodríguez S; Urology Department, University Hospital Ramon y Cajal, Madrid, Spain.
Ther Adv Urol ; 13: 17562872211043341, 2021.
Article in En | MEDLINE | ID: mdl-34552666

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Ther Adv Urol Year: 2021 Document type: Article Affiliation country: España Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Ther Adv Urol Year: 2021 Document type: Article Affiliation country: España Country of publication: Reino Unido